Citius Pharmaceuticals, Inc. Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31)
Citius Pharmaceuticals, Inc. (CTXR) reported Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) of 1.85% for the 9-month period ending 2017-06-30, per its 10-Q filed 2017-08-14.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssumptionsRiskFreeInterestRate · last filed 2018-05-11
- Citius Pharmaceuticals, Inc. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for the quarter ending 2016-12-31 was 1.93%, a 9.66% increase year-over-year.
- Citius Pharmaceuticals, Inc. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for the quarter ending 2015-12-31 was 1.76%, a 6.67% increase year-over-year.
- Citius Pharmaceuticals, Inc. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for the quarter ending 2014-12-31 was 1.65%.
- Citius Pharmaceuticals, Inc. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for fiscal 2016 was 1.14%.
- Citius Pharmaceuticals, Inc. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for fiscal 2014 was 1.83%.
| Period end | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 3 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 6 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 9 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 12 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|
| 2017-06-30 | 1.85% 10-Q · filed 2017-08-14 | ||||
| 2017-03-31 | 1.96% 10-Q · filed 2018-05-11 | ||||
| 2016-12-31 | 1.93% 10-Q · filed 2018-02-14 | ||||
| 2016-09-30 | 1.14% 10-K · filed 2017-12-13 | ||||
| 2016-06-30 | 1.01% 10-Q · filed 2016-08-15 | ||||
| 2016-03-31 | 1.21% 10-Q · filed 2016-05-20 | ||||
| 2015-12-31 | 1.76% 10-Q · filed 2016-02-12 | ||||
| 2015-09-30 | 1.14% 10-Q · filed 2017-02-14 | 1.37% 10-K · filed 2015-12-14 | |||
| 2015-06-30 | 1.62% 10-Q · filed 2015-08-13 | ||||
| 2015-03-31 | 1.37% 10-Q · filed 2015-05-13 | ||||
| 2014-12-31 | 1.65% 10-Q · filed 2015-02-17 | ||||
| 2014-09-30 | 1.78% 10-KT · filed 2014-12-29 | 1.83% 10-K · filed 2016-12-23 | 1.78% 10-Q · filed 2015-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |